Artificial Intelligence has already proved itself as an effective tool to support the research carried out by pharmaceutical companies. However, as companies begin to invest heavily in the technology, they would be wise to explore the impact it could have commercially. In January, Paul Shawah, senior vice president of Veeva Commercial Cloud, backed Artificial Intelligence […]
Category Archives: Blogs
Role of prescription digital therapeutics and the changing nature of healthcare
Digital therapeutics (DTx) represents a collection of technologies, products, and services across healthcare and wellness. More specifically, DTx delivers evidence-based therapeutic interventions that prevent, manage, or treat medical disorders and can either supplement or supplant existing treatments for a variety of diseases and conditions. DTx differs from diagnostics, telehealth, and other digital health products, as […]
QR codes on APIs to be made mandatory by Indian govt
The Indian government has made it mandatory to put QR codes on packages of active pharmaceutical ingredients (APIs) used in medicines to curtail the menace of counterfeit and substandard drugs in the country. The new rule will become effective from January 1 next year (2023). Having QR codes on APIs will help trace pharmaceutical firms […]
Russia-Ukraine war can impact India’s pharma sector
The Russia-Ukraine war is sending tremors to Indian drug exporters, and is likely to have an adverse impact on pharma companies and the total volume of exports this fiscal. Major drug exporters, including Dr Reddy’s Laboratories Ltd, have a significant presence in the Russia-CIS region, both in terms of employees as well as the market. […]
The biggest challenges facing Orphan Drug for Rare Diseases
Wile individually rare, orphan diseases are actually collectively common, with an estimated 350 million sufferers worldwide. Since the introduction of the US Orphan Drug Act more than 30 years ago, the number of orphan designations has skyrocketed and experts are predicting worldwide sales of these drugs will reach $176 billion by the end of 20201. […]
Pharmaceutical sales – How to succeed in it
Pharmaceutical sales strategies require a patient-centric approach, strategic campaigns with personalized content across multiple media channels, and effective ad performance measurement tactics. Pharmaceutical sales is predominantly geared toward patients through direct-to-consumer advertising, and toward prescribing healthcare professionals. For either advertising approach to be successful, marketers need to produce high-quality, personalized content on the right platforms […]
Importance of problem-solving skills for medical sales reps
Medical sales reps is a demanding area. The very best medical sales people are competitive and tenacious with a great work ethic – and that’s just for starters. So, what are the key characteristics of a great medical sales representative? AMBITION AND DRIVE Ambition sits at the top of the list when […]
Emotional Intelligence strategy can Help Lead Pharma Through Tough Times
Emotional intelligence strategy helps leaders to develop self-awareness, social awareness, empathy, social skills and resilience in their leadership journey. For months, we have discussed this theme in a simple but practical manner, with the chief aim of helping leaders to survive, then thrive during tough times. By the way, tough times do not last, but […]
Why medical reps should focus on Selling with Empathy?
Empathy selling. For some medical sales reps, it’s a natural part of their personality, allowing them to connect with and understand the emotions, reactions, and motivations of those around them. For others, it’s a wishy-washy emotional nightmare. In medical sales, empathy selling is a key component in creating authentic relationships with both customers and […]
Technology Can Build a New Biopharma Business Model
The urgent, shared global race to develop an effective vaccine for the novel coronavirus (Covid-19) dramatically illustrates how the unexpected onset and rapid spread of an infectious disease can upend established biopharmaceutical R&D processes, timetables, and collaborations. It also increases conjecture about other existing and/or emerging forces that may disrupt the Biopharma Business industry identification, […]